Recent Updates — JYNT

On October 1, 2026, The Joint Corp. entered into an Asset Purchase Agreement to reacquire regional development rights in Texas from five Sellers for $8.0 million in cash due upon execution, with up to $2.0 million in additional contingent consideration based on gross sales metrics over two annual periods beginning September 1, 2026. The transaction terminates the related Regional Developer Agreements (RDAs), which were among the company's earliest agreements featuring multiple successive 10-year renewal terms. As of October 1, 2026, the Texas region comprised 141 franchised clinics; following the reacquisition, the Sellers will continue to franchise eight clinics in Texas through their affiliates. The Joint Corp. operates in the healthcare industry, specifically providing chiropractic and wellness services through a franchise model.

The Joint Corp. reported second quarter 2026 financial results for the period ended June 30, 2026. Consolidated net income increased to $653,000 from $93,000 in the prior-year period, driven by discontinued operations. Revenue grew 14% to $15.2 million, while adjusted EBITDA from continuing operations rose significantly to $1.5 million from $88,000. The company repurchased approximately 82,000 shares for $677,000 at an average price of $8.23 per share and completed three regional developer territory buybacks. Total clinic count stood at 941 as of June 30, 2026. The company reiterated its full-year 2026 guidance, projecting system-wide sales between $519 million and $552 million and consolidated adjusted EBITDA between $12.5 million and $13.5 million. The Joint Corp. operates as the nation's largest franchisor of chiropractic care through The Joint Chiropractic network.